Hypothyroidism (Low Thyroid) Levothyroxine Refills Treatment
Covered by Aetna in California

Levothyroxine 25–200mcg daily on empty stomach (1.6 mcg/kg/day full replacement dose per ATA guidelines for adults under 70 without cardiac disease); TSH target 0.5–2.5 mIU/L for most adults; TSH target 4–6 mIU/L for patients over 70–80 per ATA guidance; dose adjusted in 12.5–25mcg increments with TSH recheck at 6–8 weeks after each change

Levothyroxine + liothyronine combination therapy (20:1 T4:T3 ratio — for patients on adequate levothyroxine with persistent symptoms and normal TSH; evidence is limited but ATA guidelines acknowledge it as an option for select patients after thorough discussion); natural desiccated thyroid (Armour Thyroid, NP Thyroid — contains T4 and T3; fixed T4:T3 ratio of 4:1 which does not match endogenous secretion; ATA guidelines continue to recommend synthetic levothyroxine as first-line but acknowledge desiccated thyroid as an alternative for patients who prefer it); Tirosint gel-cap (liquid-filled capsule levothyroxine — improves absorption in patients taking PPIs, calcium, iron, or coffee with their dose)

Yes — generic levothyroxine is Tier 1 on all Aetna CA commercial plans (~$4–$15/month). Brand Synthroid is non-formulary/excluded on many Aetna Advanced Control plans; patients who clinically require brand consistency should request a formulary exception with documentation of TSH instability on generic. Liothyronine and desiccated thyroid coverage varies by specific plan — verify prior to prescribing.

ATA guidelines (established 2014 and current consensus) strongly recommend against switching between levothyroxine brands or generic manufacturers without rechecking TSH, as bioavailability differences between formulations can shift TSH by 20–40% in sensitive patients — particularly problematic at doses above 100 mcg. Pharmacy benefit managers, including those administering Aetna CA, frequently auto-substitute between generic manufacturers at the pharmacy; patients with documented TSH instability may qualify for brand-name designation with PA. Levothyroxine must be taken on empty stomach, 30–60 minutes before food; separate from calcium, iron, cholestyramine, PPIs, and antacids by at least 4 hours. Annual TSH monitoring is standard; more frequent if symptoms change, new pregnancy, or dose adjustment.

Many Aetna CA Advanced Control plans have moved brand Synthroid to non-formulary status — meaning you would pay brand cost (typically $80–$120/month) unless you obtain a formulary exception. A formulary exception is approvable when a patient has documented TSH instability or worsening symptoms specifically caused by brand switching. Dr. Bhavsar can write the prescription with 'Dispense as Written / Brand Medically Necessary' notation and submit PA documentation. If your TSH has been stable on generic for several years, switching is likely clinically safe — but both you and Dr. Bhavsar should monitor TSH 6–8 weeks after any formulation change.

Persistent symptoms despite normal TSH is a well-recognized clinical dilemma. ATA guidelines acknowledge that some patients with normal TSH on levothyroxine monotherapy report residual fatigue, brain fog, and cold intolerance that may reflect impaired peripheral T4-to-T3 conversion. Options Dr. Bhavsar can discuss include: (1) optimizing TSH to the lower half of normal (0.5–1.5 mIU/L) — some patients feel better; (2) adding low-dose liothyronine (T3) if free T3 is low-normal — evidence is limited but ATA guidelines allow it in selected patients; (3) ruling out other fatigue causes (iron deficiency anemia, sleep apnea, depression, vitamin D deficiency, adrenal insufficiency) that frequently coexist with Hashimoto's.

Levothyroxine requirements increase by approximately 30–50% in the first trimester of pregnancy due to increased TBG, elevated hCG (which has weak TSH-like activity), and fetal demand. ATA guidelines recommend increasing levothyroxine dose by approximately 2 additional doses per week (14% weekly increase) as soon as pregnancy is confirmed, then rechecking TSH every 4 weeks through the first and second trimesters. TDMD can initiate this dose adjustment via telehealth for established hypothyroid patients with a current TSH on file. However, pregnancy-related hypothyroidism management is nuanced and typically transitions to an OB or endocrinology co-manager for the duration — Dr. Bhavsar will coordinate referral.

Yes. Aetna commercial plans cover telehealth visits for Hypothyroidism (Low Thyroid) Levothyroxine Refills in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your hypothyroidism medication refills visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your hypothyroidism medication refills symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.